Staging of Alzheimer's disease-related neurofibrillary changes.

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (2006) 8.15

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77

Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci (2010) 3.61

Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35

Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging (2002) 3.34

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol (2009) 2.87

Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron (2014) 2.83

Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology (2009) 2.74

Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51

Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44

Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem (2012) 2.42

Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30

Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI. Neuroradiology (2008) 2.09

Cerebral microbleeds in the elderly: a pathological analysis. Stroke (2010) 2.04

Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 1.99

Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage (2009) 1.95

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93

Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2006) 1.90

Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88

Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: implications for Alzheimer's disease. Cell Death Differ (2011) 1.86

Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage (2009) 1.85

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. Eur J Nucl Med Mol Imaging (2014) 1.80

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol (2013) 1.75

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat Med (2014) 1.73

β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord (2012) 1.69

Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol (2010) 1.69

Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci U S A (2013) 1.67

Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66

Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus (2009) 1.65

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation (2005) 1.64

Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64

Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.63

Biology and genetics of prions causing neurodegeneration. Annu Rev Genet (2013) 1.63

Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol (2009) 1.63

The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2011) 1.57

The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.55

The role of tau in neurodegeneration. Mol Neurodegener (2009) 1.54

Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage (2009) 1.53

Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol Aging (2013) 1.53

Memory performance is related to amyloid and tau pathology in the hippocampus. J Neurol Neurosurg Psychiatry (2009) 1.52

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci U S A (2006) 1.52

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin (2013) 1.49

Neuronal activity regulates extracellular tau in vivo. J Exp Med (2014) 1.48

Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study. Neuropsychology (2005) 1.48

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain (2009) 1.48

Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One (2011) 1.45

Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease. Ann Neurol (2010) 1.45

Discrete dynamic Bayesian network analysis of fMRI data. Hum Brain Mapp (2009) 1.43

Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model. Neuron (2016) 1.42

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice. Brain (2016) 1.41

Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain (2012) 1.40

Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol Aging (2005) 1.39

Necroptosis activation in Alzheimer's disease. Nat Neurosci (2017) 1.38

Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol (2010) 1.38

Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp (2014) 1.38

Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta (2011) 1.36

Amyloid load in nondemented brains correlates with APOE e4. Neurosci Lett (2010) 1.35

Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev (2008) 1.35

Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology (2002) 1.29

Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci U S A (2009) 1.29

Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29

Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A (2014) 1.28

Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol (2000) 1.25

Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clin (2013) 1.25

Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci (2015) 1.24

Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging (2008) 1.23

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol (2010) 1.22

Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging (2010) 1.19

New developments in the diagnosis of dementia. Dtsch Arztebl Int (2010) 1.16

Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One (2011) 1.16

Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int J Alzheimers Dis (2011) 1.15

Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol (2007) 1.15

Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats. Cereb Cortex (2010) 1.14

Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem (2007) 1.10

Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord (2004) 1.10

Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10

Hierarchical anatomical brain networks for MCI prediction: revisiting volumetric measures. PLoS One (2011) 1.09

Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc (2004) 1.09

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology (2002) 1.08

Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology. J Biol Chem (2013) 1.07

Rates of decline in Alzheimer disease decrease with age. PLoS One (2012) 1.07

Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast (2010) 1.07

Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol. Neuroimage (2015) 1.07

An MRI-based method for measuring volume, thickness and surface area of entorhinal, perirhinal, and posterior parahippocampal cortex. Neurobiol Aging (2007) 1.06

Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med (2012) 1.06

Neuropathologic basis of age-associated brain atrophy. JAMA Neurol (2013) 1.05

Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging (2008) 1.05

Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging (2012) 1.04

Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging (2013) 1.04

Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst) (2008) 1.04

Tau-targeted treatment strategies in Alzheimer's disease. Br J Pharmacol (2012) 1.03

Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci (2010) 1.03

Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna) (2009) 1.03

Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Am J Pathol (2004) 1.03

Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J Neurochem (2009) 1.03

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging (1997) 7.54

Staging of Alzheimer-related cortical destruction. Eur Neurol (1993) 3.58

Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett (1986) 3.36

Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol (1991) 3.35

Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl (1996) 3.02

Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl (1998) 2.83

Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol (1990) 2.78

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging (1997) 2.59

On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol (1985) 2.58

Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol (1989) 2.56

Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol (1988) 2.55

Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol (1991) 2.41

Pathoanatomy of Parkinson's disease. J Neurol (2000) 2.16

Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol (1988) 2.11

Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol (1989) 2.09

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol (1999) 2.08

Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci (1989) 2.08

Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol (1990) 2.05

The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes. Brain Res (1989) 1.93

Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques. Neurosci Lett (1989) 1.91

Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (1996) 1.83

High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp Neurol (1998) 1.82

Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol (1997) 1.63

Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl (1998) 1.57

Functional anatomy of human hippocampal formation and related structures. J Child Neurol (1996) 1.53

Staging of Alzheimer-related cortical destruction. Int Psychogeriatr (1997) 1.44

Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging (1994) 1.42

Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol (2000) 1.37

The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res (1992) 1.30

Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord (1998) 1.30

Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci (2000) 1.29

Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm (Vienna) (1996) 1.20

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett (1999) 1.15

The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord (1999) 1.14

Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (2000) 1.14

Gender and age modify the association between APOE and AD-related neuropathology. Neurology (2001) 1.12

Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl (1995) 1.09

Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett (1987) 1.08

Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm (Vienna) (1998) 1.08

Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett (1994) 1.06

Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study. Dement Geriatr Cogn Disord (1999) 1.04

Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol (2000) 1.02

The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol (2000) 1.01

Amygdala pathology in Parkinson's disease. Acta Neuropathol (1994) 0.99

Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol (2000) 0.97

Staging of Alzheimer-type pathology: an interrater-intrarater study. Dement Geriatr Cogn Disord (1997) 0.96

Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transm Park Dis Dement Sect (1990) 0.96

Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol (1992) 0.95

Neuronal types in the claustrum of man. Anat Embryol (Berl) (1982) 0.91

Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res (1998) 0.91

Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. Neurosci Lett (1996) 0.91

The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol (2001) 0.91

Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann N Y Acad Sci (1991) 0.90

Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci (2000) 0.90

Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J Neuropathol Exp Neurol (1999) 0.89

A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging (1992) 0.88

Allocortical involvement in Huntington's disease. Neuropathol Appl Neurobiol (1992) 0.86

Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol (1999) 0.86

The pyramidal cells of Betz within the cingulate and precentral gigantopyramidal field in the human brain. A Golgi and pigmentarchitectonic study. Cell Tissue Res (1976) 0.86

On layer III pyramidal cells in the parastriate borderzone of man. J Hirnforsch (1985) 0.85

Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol (1986) 0.85

Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog Brain Res (1986) 0.85

Golgi preparations as a tool in neuropathology with particular reference to investigations of the human telencephalic cortex. Prog Neurobiol (1985) 0.85

On the fine structure of the small, heavily pigmented non-pyramidal cells in lamina II and upper lamina III of the human isocortex. Cell Tissue Res (1976) 0.84

Age-related progression of tau pathology in brains of baboons. Neurobiol Aging (2001) 0.84

Neuronal types in the striatum of man. Cell Tissue Res (1982) 0.84

On three types of large nerve cells in the granular layer of the human cerebellar cortex. Anat Embryol (Berl) (1983) 0.84

Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys. Neurobiol Aging (2001) 0.83

Entorhinal-hippocampal interaction in mnestic disorders. Hippocampus (1993) 0.83

The hypothalamus of the human adult: chiasmatic region. Anat Embryol (Berl) (1987) 0.83

On the fine structure of the external glial layer in the isocortex of man. Cell Tissue Res (1975) 0.82

Morphological studies of local circuit neurons in the cerebellar dentate nucleus of man. Hum Neurobiol (1983) 0.82

[Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems]. Nervenarzt (2000) 0.81

Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons. J Neuropathol Exp Neurol (2000) 0.81

New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease. J Neural Transm Suppl (1996) 0.81

Parvalbumin-immunoreactive structures of the adult human entorhinal and transentorhinal region. Hippocampus (1993) 0.81

Parvalbumin-immunoreactive neurons in the human claustrum. Brain Struct Funct (2013) 0.81

A sex difference in neurodegeneration of the human hypothalamus. Neurosci Lett (1996) 0.81

Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer's disease. Exp Neurol (1999) 0.81

Isocortical pathology in type C Niemann-Pick disease. A combined Golgi-pigmentoarchitectonic study. J Neuropathol Exp Neurol (1983) 0.81

The fine structure of myelinated nerve cell bodies in the bulbus olfactorius of man. Cell Tissue Res (1977) 0.80

Age-related alterations of the proximal axon segment in lamina IIIab-pyramidal cells of the human isocortex. A Golgi and fine structural study. J Hirnforsch (1980) 0.80

A method of firmly attaching 4-10micron thick araldite serial sections to glass slides for light microscopic staining procedures. Stain Technol (1977) 0.80

[Do the island neurons of regio entorhinalis belong to the class of pyramid or star-shaped cells?]. Z Mikrosk Anat Forsch (1976) 0.80

Calbindin-D-28k-like immunoreactive structures in the olfactory bulb and anterior olfactory nucleus of the human adult: distribution and cell typology--partial complementarity with parvalbumin. Neuroscience (1991) 0.79

Glutamic acid decarboxylase immunoreactivity in sector CA1 of the human Ammon's horn. Anat Embryol (Berl) (1986) 0.79

Neurofibrillary pathology in the human paraventricular and supraoptic nuclei. Acta Neuropathol (1997) 0.79

Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 allele. Acta Neuropathol (1998) 0.79

[Morphological changes in the human cerebral cortex in dementia]. J Hirnforsch (1991) 0.79

Projection neurons of basolateral amygdaloid nuclei develop meganeurites in juvenile and adult human neuronal ceroid lipofuscinosis. Clin Neuropathol (1987) 0.79

[Staining the Nissl bodies in 4--10 microns thick Araldite sections with an area of about 2x2 cm (author's transl)]. Microsc Acta (1976) 0.79

On the structure of the human striate area. Lamina IVcbeta. Cell Tissue Res (1978) 0.78

Tau pathology in neurons and glial cells of aged baboons. Adv Exp Med Biol (2001) 0.78

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Brain Res (1998) 0.78

Anatomy of the human hypothalamus (chiasmatic and tuberal region). Prog Brain Res (1992) 0.78

Pigment-filled appendages of the small spiny neurons: a severe pathological change of the striatum in neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol (1980) 0.78

Involvement of precerebellar nuclei in Pick's disease. Exp Neurol (1998) 0.77